•HRES 688 IH 
Whereas as a result, the GAVI Alliance has played a critical 
role in increasing the number of global vaccine manufac-
turers selling to the world’s poorest countries from 5 in 
2001 to 13 in 2014; 
Whereas the price for the pneumococcal vaccine, which pre-
vents pneumonia, is now more than 90 percent lower for 
GAVI-eligible countries, and the price of rotavirus vac-
cines, which prevents diarrhea, is 67 percent lower in 
GAVI-eligible countries; 
Whereas with innovative financing mechanisms like the Ad-
vance Market Commitment and International Finance 
Facility for Immunisation (IFFIm), the GAVI Alliance 
ensures that appropriate and affordable vaccines are 
available throughout the developing world; 
Whereas the GAVI Alliance supports the financing and deliv-
ery of 11 vaccines, including those against pneumococcal 
disease and rotavirus, the leading vaccine-preventable 
causes of pneumonia and diarrhea, which kill more chil-
dren under the age of 5 than any other disease; 
Whereas the GAVI Alliance collaborates closely with the 
Global Polio Eradication Initiative on the final push to 
end polio, strengthening and bringing the inactivated 
polio vaccine into routine immunization programs; 
Whereas strong immunization systems are critical to ensuring 
continuous coverage and sustainability of polio, new and 
routine immunization programs in implementing coun-
tries; 
Whereas the GAVI Alliance supports the strengthening of 
health systems and local civil society organizations to en-
sure effective immunization and health services; 
VerDate Mar 15 2010 
00:58 Jul 26, 2014
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR688.IH
HR688
tjames on DSK5VPTVN1PROD with BILLS
•HRES 688 IH 
Whereas since 2000, with support from the United States, 
the Bill & Melinda Gates Foundation, UNICEF, the 
World Health Organization, the World Bank, imple-
menting countries, donor governments, the private sector, 
and other donors and partners, the GAVI Alliance has 
supported country-led vaccine roll outs in 77 countries to 
support the immunization of an additional 440,000,000 
children and will avert an estimated 6,000,000 deaths in 
the world’s poorest countries; 
Whereas in 2013, the GAVI Alliance was ranked the second 
most transparent aid program in the Aid Transparency 
Index, behind only the Millennium Challenge Corpora-
tion; 
Whereas even with significant contributions by the GAVI Al-
liance, only a small percentage of young children world-
wide receive all 11 life-saving vaccines universally rec-
ommended by the World Health Organization; 
Whereas vaccines are widely regarded as one of the ‘‘best 
buys’’ in global health and recognized as one of the most 
efficient, cost-effective, and successful health initiatives in 
history; 
Whereas in 2012, leading experts on health economics ranked 
childhood immunization as 1 of the 3 most cost-effective 
solutions to advance global health; 
Whereas as one of the initial 6 donors, the United States has 
been an important supporter of the GAVI Alliance and 
through the generosity of the people of the United States 
has contributed almost $1,200,000,000 for the acquisi-
tion of life saving vaccines; 
Whereas at the GAVI Alliance’s first pledging conference in 
June 2011, the United States increased its support and 
VerDate Mar 15 2010 
00:58 Jul 26, 2014
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6300
E:\BILLS\HR688.IH
HR688
tjames on DSK5VPTVN1PROD with BILLS
•HRES 688 IH 
pledged $450,000,000 for fiscal years 2012 through 2014 
to increase access to new and underused vaccines, includ-
ing pneumococcal and rotavirus vaccines; 
Whereas in addition to this 3-year pledge, the United States 
contributed an additional $90,000,000 to the GAVI Alli-
ance in fiscal year 2011; 
Whereas United States investment in the GAVI Alliance com-
plements and enhances the effectiveness of other bilateral 
and multilateral United States investments in global 
health, particularly in child survival; 
Whereas the GAVI Alliance is committed to working with 
partners, including United States bilateral programs run 
by the United States Agency for International Develop-
ment (USAID) and the Centers for Disease Control and 
Prevention (CDC), to ensure children in developing na-
tions have access to vaccines and immunizations; 
Whereas in June 2012, the United States Government, to-
gether with the Governments of Ethiopia and India as 
well as UNICEF, mobilized the world around the goal of 
ending preventable child deaths by 2035; 
Whereas access to immunizations is a key component of 
reaching that goal; 
Whereas in May 2014, at the World Economic Forum meet-
ing in Abuja, Nigeria, African leaders pledged to increase 
investment in their countries’ immunization programs by 
endorsing the Immunise Africa 2020 leaders declaration; 
Whereas, on May 20, 2014, the GAVI Alliance called on do-
nors to support an ambitious plan to immunize an addi-
tional 300,000,000 children against potentially fatal dis-
eases and save an additional 5,000,000 to 6,000,000 lives 
between 2016 and 2020; 
VerDate Mar 15 2010 
00:58 Jul 26, 2014
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6300
E:\BILLS\HR688.IH
HR688
tjames on DSK5VPTVN1PROD with BILLS
•HRES 688 IH 
Whereas the GAVI Alliance needs donors to invest an addi-
tional $7,500,000,000 to support developing countries’ 
immunization programs from 2016 to 2020; 
Whereas at the same time, implementing countries are ex-
pected to co-finance an additional $1,200,000,000, an in-
crease from almost $500,000,000 in 2011 through 2015; 
and 
Whereas with this support from donors and the global vaccine 
community, 
the 
GAVI 
Alliance 
can 
reach 
its 
1,000,000,000th child with critical vaccines by the early 
2020s, nearly double the number of lives saved since its 
founding and unlock between $80,000,000,000 to 
$100,000,000,000 in economic benefits through health 
care savings and productivity gains: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) commends the GAVI Alliance, the Bill and 
Melinda Gates Foundation, the United Nations Chil-
dren’s Emergency Fund (UNICEF), the World 
Health Organization, the World Bank, civil society, 
the private sector, faith-based organizations, the 
international community, and implementing coun-
tries on the progress that has been made on reduc-
ing child mortality through the increased availability 
and distribution of vaccines; 
(2) affirms the United States continued support 
for the purchase of vaccines for poor countries 
through the GAVI Alliance as a cost-effective, effi-
cient means to reduce child mortality and as a crit-
VerDate Mar 15 2010 
00:58 Jul 26, 2014
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\HR688.IH
HR688
tjames on DSK5VPTVN1PROD with BILLS
•HRES 688 IH 
ical component of meeting the United States goal to 
end preventable maternal and child deaths; 
(3) supports the ideals and goals of the GAVI 
Alliance— 
(A) accelerate equitable uptake and cov-
erage of vaccines; 
(B) improve the effectiveness and effi-
ciency of immunization delivery; 
(C) improve sustainability of national im-
munization programs; and 
(D) shape markets for vaccines and other 
immunization products; 
(4) upholds that the United States is a critical 
donor in its work with other donors to perform dip-
lomatic outreach in seeking additional funding for 
the GAVI Alliance in order to leverage its commit-
ment; 
(5) recognizes that the United States, in addi-
tion to being an important donor, is a critical tech-
nical partner to the GAVI Alliance and the impact 
of United States investments to the GAVI Alliance 
is leveraged by providing direct technical assistance 
to implementing countries and global bodies; 
(6) encourages the continued use of United 
States 
Agency 
for 
International 
Development 
VerDate Mar 15 2010 
00:58 Jul 26, 2014
Jkt 039200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\HR688.IH
HR688
tjames on DSK5VPTVN1PROD with BILLS